Bio Green Med Solution (BGMS) Short-term Investments (2011 - 2022)

Bio Green Med Solution (BGMS) has reported Short-term Investments for 7 consecutive years, with $4.5 million the latest figure, recorded in Q4 2022.

• In Q4 2022, Short-term Investments rose 1.56% year-over-year to $4.5 million; the TTM figure through Dec 2022 stood at $4.5 million (up 1.56% YoY), while the FY2022 annual figure was $4.5 million, up 1.56% from the prior year.
• Short-term Investments advanced to $4.5 million in Q4 2022 per BGMS's latest filing, from $4.5 million in the prior quarter.
• Across five years, Short-term Investments topped out at $16.7 million in Q4 2018 and bottomed at $4.5 million in Q4 2021.
• Historically, Short-term Investments has averaged $8.4 million across 5 years, with a median of $5.3 million in 2020.
• Annual changes were most pronounced in 2020 — Short-term Investments slumped 52.2% — and 2022, when it advanced 1.56%.
• Bio Green Med Solution's Short-term Investments stood at $16.7 million in 2018, then plunged by 33.23% to $11.1 million in 2019, then sank by 52.2% to $5.3 million in 2020, then slipped by 15.94% to $4.5 million in 2021, then rose by 1.56% to $4.5 million in 2022.
• Business Quant data shows BGMS's Short-term Investments at $4.5 million in Q4 2022, $4.5 million in Q4 2021, and $5.3 million in Q4 2020.